New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies-Reference-Cited by-同舟云学术

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Published:2019-04-09 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Scuteri Damiana,Adornetto Annagrazia,Rombolà Laura,Naturale Maria Diana,Morrone Luigi Antonio,Bagetta Giacinto,Tonin Paolo,Corasaniti Maria Tiziana

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference47 articles.

1. Appendix a: summary of evidence-based guideline for clinicians, update: pharmacologic treatment for episodic migraine prevention in adults.;Continuum,2015

2. Personalized medicine: theranostics (therapeutics diagnostics) essential for rational use of tumor necrosis factor-alpha antagonists.;Bendtzen;Discov. Med.,2013

3. Pharmacokinetics of immunoglobulin administered via intravenous or subcutaneous routes.;Bonilla;Immunol. Allergy Clin. North Am.,2008

4. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the global burden of disease study 2016.;Collaborators;Lancet Neurol.,2018

5. Prophylaxis of migraine: general principles and patient acceptance.;D’Amico;Neuropsychiatr. Dis. Treat.,2008

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs;Journal of Virology;2024-07-23

2. The evolving landscape and research trend of calcitonin gene-related peptide in migraine: A bibliometric analysis and visualization;Frontiers in Neurology;2024-06-24

3. Exploring potential neuroimaging biomarkers for the response to non-steroidal anti-inflammatory drugs in episodic migraine;The Journal of Headache and Pain;2024-06-21

4. Comparative Long-Term Effectiveness Of OnabotulinumtoxinA (Botox) And Anti CGRP In Migraine Prevention: A Systematic Review;F1000Research;2024-06-20

5. Reporting Quality and Risk of Bias Analysis of Published RCTs Assessing Anti-CGRP Monoclonal Antibodies in Migraine Prophylaxis: A Systematic Review;Journal of Clinical Medicine;2024-03-28